Topical buparvaquone formulations for the treatment of cutaneous leishmaniasis

Keyphrases

• Buparvaquone 100%
• Cutaneous Leishmaniasis 100%
• Prodrug 33%
• Topical Application 16%
• Antileishmanial 16%
• Full-thickness 16%
• ED50 8%
• Murine Skin 8%
• In Vivo Model 8%
• Epidermal Membrane 8%
• Topical Delivery 8%
• Weight-based 8%
• Franz Diffusion Cell 8%
• In Vitro Binding 8%
• Human Skin 8%
• Inactive Ingredients 8%
• Topical Formulation 8%
• Gel Formulation 8%
• Melanin 8%
• Dose Effect 8%
• Membrane Thickness 8%
• Microgels 8%
• Regulatory Process 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Buparvaquone 100%
• Skin Leishmaniasis 100%
• Prodrug 33%
• Melanin 8%
• Excipient 8%